A new trading day began on Monday, with Bionano Genomics Inc (NASDAQ: BNGO) stock price down -1.63% from the previous day of trading, before settling in for the closing price of $0.23. BNGO’s price has ranged from $0.19 to $1.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 44.98% over the last five years. Meanwhile, its annual earnings per share averaged 77.19%. With a float of $139.11 million, this company’s outstanding shares have now reached $139.82 million.
The firm has a total of 344 workers. Let’s measure their productivity. In terms of profitability, gross margin is -1.8%, operating margin of -324.25%, and the pretax margin is -407.35%.
Bionano Genomics Inc (BNGO) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Bionano Genomics Inc is 0.51%, while institutional ownership is 3.90%.
Bionano Genomics Inc (BNGO) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.19% per share during the next fiscal year.
Bionano Genomics Inc (NASDAQ: BNGO) Trading Performance Indicators
Here are Bionano Genomics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.31, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Bionano Genomics Inc (BNGO)
Analysing the last 5-days average volume posted by the [Bionano Genomics Inc, BNGO], we can find that recorded value of 16.78 million was lower than the volume posted last year of 26.18 million. As of the previous 9 days, the stock’s Stochastic %D was 12.83%. Additionally, its Average True Range was 0.04.
During the past 100 days, Bionano Genomics Inc’s (BNGO) raw stochastic average was set at 7.56%, which indicates a significant decrease from 15.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 194.34% in the past 14 days, which was higher than the 102.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2488, while its 200-day Moving Average is $0.5656. Now, the first resistance to watch is $0.2307. This is followed by the second major resistance level at $0.2386. The third major resistance level sits at $0.2522. If the price goes on to break the first support level at $0.2092, it is likely to go to the next support level at $0.1956. Now, if the price goes above the second support level, the third support stands at $0.1877.
Bionano Genomics Inc (NASDAQ: BNGO) Key Stats
With a market capitalization of 31.17 million, the company has a total of 116,924K Shares Outstanding. Currently, annual sales are 36,120 K while annual income is -232,490 K. The company’s previous quarter sales were 6,070 K while its latest quarter income was -44,250 K.
